An open-label, prospective, safety, tolerability and pharmacokinetics study of AQU-005 for the treatment of neuropathic pain
Latest Information Update: 30 Jun 2016
At a glance
- Drugs AQU 005 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- 30 Jun 2016 New trial record